Intolerance to statins: mechanisms and management

Diabetes Care. 2013 Aug;36 Suppl 2(Suppl 2):S325-30. doi: 10.2337/dcS13-2038.

Authors

Rafael Bitzur¹, Hofit Cohen, Yehuda Kamari, Dror Harats

Affiliation

¹ Bert W. Strassburger Lipid Center, Sheba Medical Center, Tel Hashomer, Israel. rafael.bitzur@sheba.health.gov.il

No abstract available

Publication types

Review

MeSH terms

Cardiovascular Diseases / drug therapy
Cardiovascular Diseases / genetics
Cardiovascular Diseases / mortality
Drug-Related Side Effects and Adverse Reactions / etiology*
Drug-Related Side Effects and Adverse Reactions / therapy*
Genetic Predisposition to Disease
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Immune System / drug effects
Immune System / physiology
Mitochondria, Muscle / drug effects
Mitochondria, Muscle / physiology
Muscular Diseases / chemically induced
Muscular Diseases / epidemiology
Muscular Diseases / genetics
Muscular Diseases / therapy

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors